1 Report Prologue
1.1 Introduction
1.1.1Global Electrochemical Biosensors Market, By Application
1.1.2Global Electrochemical Biosensors Market, By End User
1.1.3Global Electrochemical Biosensors Market, By Region

2 Introduction
2.1 Definition
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure

3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research

4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing diabetic population
4.2.2 Rising prevalence of chronic and lifestyle induced disease
4.2.3 Increasing demand for POCT
4.2.4 Increasing application of biosensors in various industries
4.3 Restraints
4.3.1 Strict regulatory requirements
4.3.2 Reimbursement policies issues in healthcare systems
4.4 Opportunities
4.4.1 Opportunity from increasing demand of personalized medicine

5 Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Buyers
5.1.2 Bargaining Power of Suppliers
5.1.3 Threat of New Entrants
5.1.4 Intensity of Rivalry
5.1.5 Threat of Substitutes

6 Global Electrochemical Biosensors Market, By Application
6.1 Introduction
6.2 Diagnosis
6.3 Monitoring
6.4 Other Applications

7 Global Electrochemical Biosensors Market, By End User
7.1 Introduction
7.2 Point of Care Testing
7.3 Diagnostics Center
7.4 Research Laboratories

8 Global Electrochemical Biosensors Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 France
8.3.3 U.K
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Republic of Korea
8.4.5 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa

9 Competitive Landscape
9.1 Introduction

10 Company Profile
10.1 F. Hoffmann-La Roche AG
10.1.1 Company Overview
10.1.2 Product/Business Segment Overview
10.1.3 Financials
10.1.4 Key Developments
10.2 Medtronics
10.2.1 Company Overview
10.2.2 Product/Business Segment Overview
10.2.3 Financial Overview
10.2.4 Key Development
10.3 Bayer AG
10.3.1 Company Overview
10.3.2 Product/Business Segment Overview
10.3.3 Financial Updates
10.4 Abbott Laboratories
10.4.1 Company Overview
10.4.2 Product/Business Segment Overview
10.4.3 Financial Updates
10.5 I-SENS, Inc.
10.5.1 Company Overview
10.5.2 Product/Business Segment Overview
10.5.3 Financial Updates
10.5.4 Key Development
10.6 Siemens Healthcare GmbH
10.6.1 Company Overview
10.6.2 Product/Business Segment Overview
10.6.3 Financial Updates
10.6.4 Key Development